🇺🇸 FDA
Patent

US 8541371

Treatment of conditions related to cecal ligation shock

granted A61KA61K31/495A61K38/1722

Quick answer

US patent 8541371 (Treatment of conditions related to cecal ligation shock) held by The Regents of the University of California expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/495, A61K38/1722, A61K38/38, A61K38/57